‘They just were not all in’: How the White House convinced two pharmaceutical giants to collaborate on a vaccine
President Joe Biden’s coronavirus response team learned two things his first week in office: Johnson & Johnson’s one-shot coronavirus vaccine was highly effective — but the company was millions of doses behind its production schedule. Preliminary conversations that began under the Trump administration about a vaccine manufacturing partnership between the pharmaceutical giant and its competitor,
Continue Reading